Skip to content

RoosterBio

Site Navigation

  • Our Technology
    • Foundation for Multiple Therapeutics
    • Powerful Technology
    • Built-In Manufacturing Process
  • Products
    • High Volume hMSCs
      • XF hBM-MSCs
      • XF hUC-MSCs
      • XF RTP hBM-MSCs
      • Traditional hBM-MSCs
      • Traditional RTP hBM-MSCs
    • hMSC Bioprocess Media
      • XF hMSC Bioprocess Media
      • XF hMSC Bioreactor Feeds
      • XF hMSC Bioprocess Supplements & Reagents
      • Traditional hMSC Bioprocess Media
    • CliniControl Products
      • CliniControl High Volume hMSCs
      • CliniControl hMSC Bioprocess Media
      • CliniControl Extracellular Vesicle (EV) Production
    • Extracellular Vesicle (EV) Production
      • EV Collection Media
      • EV Supplements & Reagents
    • hMSC Kits
      • RoosterVial & RoosterNourish Test Kits
      • Donor Screening Test Kits
      • Bioreactor Starter Kits
      • Bioreactor Development Kits
      • Bioprinting Kits
      • Bioprinting RTP Kits
  • Services
    • Process Development Services
  • Knowledge Center
    • Resources
    • Blog Articles
    • Publications
  • About Us
    • Why RoosterBio?
    • Our Leadership
    • Our Collaborators
    • Our Culture
    • Careers
  • News & Events
    • News
    • Events
    • Press Releases
    • Media Kit
  • Contact Us

Press Releases

RoosterBio Expands Facility for Second Time in 2019

December 18, 2019

Australian Patent Office Grants Patent Covering RoosterBio’s Novel Compositions and Formulations for Ready-to-Print (RTP) Cells

September 30, 2019

RoosterBio Closes Final Tranche of Oversubscribed $21.5 Million Series B Raise and Appoints Daniella Kranjac to the Board

September 10, 2019

RoosterBio Launches the Only Umbilical Cord hMSC System in the World Designed for Cell Therapy Product Development

September 6, 2019

RoosterBio Cell Manufacturing Experts and Biomanufacturing Leaders to Discuss hMSC BioProcess Solutions at Biotech Week Boston

September 4, 2019

RoosterBio Raises $15 Million in Initial Series B Round Led by Dynamk Capital

August 6, 2019

RoosterBio Named a 2019 Best Place to Work

August 1, 2019

RoosterBio’s Ready to Print MSCs Used in Partnership with nScript, U.S. Military, the Uniformed Services University 4D Bio3 Program to Test Bioprinter

July 10, 2019

RoosterBio Receives Grant from Maryland Stem Cell Research Fund to Commercialize MSC-EV Technology

June 13, 2019

Winners of First RoosterBio Inc. hMSC Development Grant Announced

June 4, 2019
Previous 1 2 3 4 5 6 Next

Sidebar Navigation

Careers

Contact Us

Contact Information

RoosterBio, Inc.
Email: info@roosterbio.com Phone: +1 301-200-5366

Share

  • Twitter
  • Facebook
  • YouTube
  • LinkedIn
  • Email

Copyright © 2021 RoosterBio, Inc. All Rights Reserved / Privacy Policy / Website design by Wood Street, Inc.